Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 45% ± 20% | |
endothelial cell | 9 studies | 24% ± 7% | |
endothelial cell of lymphatic vessel | 8 studies | 28% ± 9% | |
ciliated cell | 8 studies | 27% ± 9% | |
glutamatergic neuron | 5 studies | 38% ± 12% | |
plasma cell | 4 studies | 32% ± 2% | |
GABAergic neuron | 4 studies | 31% ± 14% | |
capillary endothelial cell | 3 studies | 18% ± 0% | |
interneuron | 3 studies | 23% ± 8% | |
ependymal cell | 3 studies | 45% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 3135.12 | 2541 / 2642 | 100% | 51.57 | 703 / 705 |
thymus | 93% | 824.30 | 608 / 653 | 87% | 3.57 | 528 / 605 |
prostate | 82% | 1008.16 | 201 / 245 | 51% | 1.12 | 257 / 502 |
esophagus | 68% | 1286.07 | 988 / 1445 | 64% | 1.82 | 117 / 183 |
lung | 62% | 424.10 | 361 / 578 | 67% | 1.95 | 777 / 1155 |
uterus | 98% | 2736.84 | 166 / 170 | 31% | 0.96 | 143 / 459 |
kidney | 62% | 393.25 | 55 / 89 | 65% | 5.82 | 587 / 901 |
intestine | 87% | 2828.52 | 836 / 966 | 36% | 0.79 | 189 / 527 |
ovary | 49% | 372.91 | 88 / 180 | 70% | 2.68 | 301 / 430 |
stomach | 45% | 847.33 | 161 / 359 | 58% | 2.41 | 165 / 286 |
bladder | 76% | 740.14 | 16 / 21 | 25% | 0.63 | 126 / 504 |
breast | 33% | 196.86 | 153 / 459 | 66% | 1.30 | 733 / 1118 |
muscle | 96% | 2117.19 | 769 / 803 | 0% | 0 | 0 / 0 |
spleen | 94% | 841.21 | 226 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 66.47 | 31 / 258 | 68% | 5.26 | 156 / 230 |
tonsil | 0% | 0 | 0 / 0 | 64% | 1.40 | 29 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.68 | 17 / 29 |
pancreas | 0% | 1.13 | 1 / 328 | 54% | 1.38 | 96 / 178 |
heart | 46% | 299.83 | 396 / 861 | 0% | 0 | 0 / 0 |
skin | 2% | 9.85 | 34 / 1809 | 39% | 0.78 | 183 / 472 |
adipose | 29% | 215.95 | 347 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 22% | 0.41 | 90 / 406 |
blood vessel | 22% | 132.26 | 291 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 1519.14 | 182 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0005737 | Cellular component | cytoplasm |
GO_0016286 | Molecular function | small conductance calcium-activated potassium channel activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005242 | Molecular function | inward rectifier potassium channel activity |
Gene name | KCNN3 |
Protein name | Small conductance calcium-activated potassium channel subfamily N member 3 variant 1A Small-conductance calcium-activated potassium channel SK3 Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3) Potassium calcium-activated channel subfamily N member 3 |
Synonyms | K3 |
Description | FUNCTION: Forms a voltage-independent potassium channel activated by intracellular calcium . Activation is followed by membrane hyperpolarization (By similarity). Thought to regulate neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization (By similarity). . |
Accessions | A0A087WYJ0 ENST00000618040.4 ENST00000358505.2 [Q9UGI6-3] Q96DJ3 ENST00000271915.9 [Q9UGI6-1] Q86VF8 Q9UGI6 ENST00000361147.8 [Q9UGI6-2] |